Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

GSK3 inhibition prevents lethal GVHD in mice.

Klamer G, Shen S, Song E, Rice AM, Knight R, Lindeman R, O'Brien TA, Dolnikov A.

Exp Hematol. 2013 Jan;41(1):39-55.e10. doi: 10.1016/j.exphem.2012.09.005. Epub 2012 Sep 19.

PMID:
22999867
2.
5.

Small-molecule inhibitor of glycogen synthase kinase 3β 6-Bromoindirubin-3-oxime inhibits hematopoietic regeneration in stem cell recipient mice.

Shen S, Xu N, Klamer G, Ko KH, Khoo M, Ma D, Moore J, O'Brien TA, Dolnikov A.

Stem Cells Dev. 2015 Mar 15;24(6):724-36. doi: 10.1089/scd.2014.0230. Epub 2014 Dec 9.

PMID:
25329250
7.
9.

New strategies in allogeneic stem cell transplantation: immunotherapy using irradiated allogeneic T cells.

Waller EK, Boyer M.

Bone Marrow Transplant. 2000 May;25 Suppl 2:S20-4.

PMID:
10933181
10.

Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.

Gendelman M, Yassai M, Tivol E, Krueger A, Gorski J, Drobyski WR.

Biol Blood Marrow Transplant. 2003 Dec;9(12):742-52.

11.

Characterization of graft-versus-host disease in SCID mice and prevention by physicochemical stressors.

Sheng-Tanner X, McKerlie C, Spaner D.

Transplantation. 2000 Dec 27;70(12):1683-93.

PMID:
11152097
12.

Opposing roles of interferon-gamma on CD4+ T cell-mediated graft-versus-host disease: effects of conditioning.

Welniak LA, Blazar BR, Anver MR, Wiltrout RH, Murphy WJ.

Biol Blood Marrow Transplant. 2000;6(6):604-12.

13.

Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.

Tian Y, Deng YB, Huang YJ, Wang Y.

Immunol Invest. 2008;37(1):29-42. doi: 10.1080/08820130701410223.

PMID:
18214798
14.

GSK-3β inhibition preserves naive T cell phenotype in bone marrow reconstituted mice.

Shen S, Klamer G, Xu N, O'Brien TA, Dolnikov A.

Exp Hematol. 2013 Dec;41(12):1016-27.e1. doi: 10.1016/j.exphem.2013.08.006. Epub 2013 Sep 7.

PMID:
24018603
15.

Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients.

Blazar BR, Sharpe AH, Chen AI, Panoskaltsis-Mortari A, Lees C, Akiba H, Yagita H, Killeen N, Taylor PA.

Blood. 2003 May 1;101(9):3741-8. Epub 2003 Jan 9.

16.

Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).

Taylor PA, Panoskaltsis-Mortari A, Freeman GJ, Sharpe AH, Noelle RJ, Rudensky AY, Mak TW, Serody JS, Blazar BR.

Blood. 2005 Apr 15;105(8):3372-80. Epub 2004 Dec 23.

17.
19.

7-Bromoindirubin-3'-oxime induces caspase-independent cell death.

Ribas J, Bettayeb K, Ferandin Y, Knockaert M, Garrofé-Ochoa X, Totzke F, Schächtele C, Mester J, Polychronopoulos P, Magiatis P, Skaltsounis AL, Boix J, Meijer L.

Oncogene. 2006 Oct 12;25(47):6304-18. Epub 2006 May 15.

PMID:
16702956
20.

[Immune tolerance induced by cytokines in allogeneic hematopoietic stem cell transplantation].

Chang YJ, Huang XJ.

Beijing Da Xue Xue Bao. 2009 Apr 18;41(2):208-11. Chinese.

Supplemental Content

Support Center